Similar to the results obtained with AZD1390, we found that the addition of AZD0156 to radiation and anti–PD-L1 therapies significantly inhibited mT4 tumor growth and volume doubling (as compared with radiation+anti–PD-L1; Figure 3, D and E). The gene discussed is CD274; the disease is neoplasm.